BRPI0418255A - unsubstituted piperazine and piperidine derivatives - Google Patents
unsubstituted piperazine and piperidine derivativesInfo
- Publication number
- BRPI0418255A BRPI0418255A BRPI0418255-3A BRPI0418255A BRPI0418255A BR PI0418255 A BRPI0418255 A BR PI0418255A BR PI0418255 A BRPI0418255 A BR PI0418255A BR PI0418255 A BRPI0418255 A BR PI0418255A
- Authority
- BR
- Brazil
- Prior art keywords
- piperidine derivatives
- unsubstituted piperazine
- piperazine
- disorders
- unsubstituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/08—Mydriatics or cycloplegics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Ophthalmology & Optometry (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Obesity (AREA)
- Addiction (AREA)
- Hospice & Palliative Care (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Child & Adolescent Psychology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Anesthesiology (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
"DERIVADOS DE PIPERAZINA E PIPERIDINA N-SUBSTITUìDOS". Esta invenção se relaciona com compostos de fórmula 1, em que R¬ 1¬, R¬ 2¬, R¬ 7¬, R¬ 8¬, R¬ 9¬, U, V, Z, A, W, X, M, E, L, T e D são definidos conforme a especificação, composições farmacêuticas que os contêm e uso deles no tratamento de distúrbios do sistema nervoso central e de outros distúrbios."N-REPLACED PIPERAZINE AND PIPERIDINE DERIVATIVES". This invention relates to compounds of formula 1 wherein R¬1¬, R¬2¬, R¬7¬, R¬8 V, R¬9¬, U, V, Z, A, W, X, M , E, L, T and D are defined according to the specification, pharmaceutical compositions containing them and their use in the treatment of central nervous system disorders and other disorders.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US53376103P | 2003-12-31 | 2003-12-31 | |
PCT/IB2004/004239 WO2005066165A1 (en) | 2003-12-31 | 2004-12-20 | N-substituted piperidine and piperazine derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0418255A true BRPI0418255A (en) | 2007-04-17 |
Family
ID=34748954
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0418255-3A BRPI0418255A (en) | 2003-12-31 | 2004-12-20 | unsubstituted piperazine and piperidine derivatives |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1701954A1 (en) |
JP (1) | JP2007517014A (en) |
BR (1) | BRPI0418255A (en) |
CA (1) | CA2551346A1 (en) |
MX (1) | MXPA06007654A (en) |
WO (1) | WO2005066165A1 (en) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1560814A1 (en) * | 2002-11-13 | 2005-08-10 | Synthon B.V. | Process for making risperidone and intermediates therefor |
WO2008020306A2 (en) * | 2006-08-18 | 2008-02-21 | Pfizer Products Inc. | Isoindole derivatives |
US20080186971A1 (en) * | 2007-02-02 | 2008-08-07 | Tarari, Inc. | Systems and methods for processing access control lists (acls) in network switches using regular expression matching logic |
ES2885698T3 (en) | 2009-06-25 | 2021-12-15 | Alkermes Pharma Ireland Ltd | Prodrugs of NH-Acid Compounds |
NZ597107A (en) | 2009-06-25 | 2013-12-20 | Alkermes Pharma Ireland Ltd | Heterocyclic compounds for the treatment of neurological and psychological disorders |
KR101756495B1 (en) * | 2010-03-11 | 2017-07-10 | 다이닛본 스미토모 세이야꾸 가부시끼가이샤 | N-acyl cyclic amine derivative or pharmaceutically acceptable salt thereof |
ES2691671T3 (en) | 2010-06-24 | 2018-11-28 | Alkermes Pharma Ireland Limited | Prodrugs of NH-acidic compounds: ester, carbonate, carbamate and phosphonate derivatives |
EP2685979B1 (en) | 2011-03-18 | 2016-08-24 | Alkermes Pharma Ireland Limited | Injectable pharmaceutical compositions comprising a water-insoluble anti-psychotic, sorbitan laurate and polysorbate 20 |
JP5715605B2 (en) * | 2011-09-14 | 2015-05-07 | 大日本住友製薬株式会社 | Pharmaceutical comprising N-acyl cyclic amine derivative or pharmaceutically acceptable salt thereof |
ES2715562T3 (en) | 2011-12-15 | 2019-06-04 | Alkermes Pharma Ireland Ltd | Prodrugs of secondary amine compounds |
EP2827866B1 (en) | 2012-03-19 | 2023-05-03 | Alkermes Pharma Ireland Limited | Pharmaceutical compositions comprising benzyl alcohol |
WO2013142198A1 (en) | 2012-03-19 | 2013-09-26 | Alkermes Pharma Ireland Limited | Pharmaaceutical compositions comprising fatty acid esters |
JP6219918B2 (en) | 2012-03-19 | 2017-10-25 | アルカームス ファーマ アイルランド リミテッド | Pharmaceutical composition comprising glycerol ester |
WO2014080285A2 (en) | 2012-09-19 | 2014-05-30 | Alkermes Pharma Ireland Limited | Pharmaceutical compositions having improved storage stability |
PL3071203T3 (en) | 2013-11-18 | 2021-08-23 | Forma Therapeutics, Inc. | Tetrahydroquinoline compositions as bet bromodomain inhibitors |
EP3071205B1 (en) | 2013-11-18 | 2020-02-05 | Forma Therapeutics, Inc. | Benzopiperazine compositions as bet bromodomain inhibitors |
US9452131B2 (en) | 2014-03-20 | 2016-09-27 | Alkermes Pharma Ireland Limited | Aripiprazole formulations having increased injection speeds |
CN112423754A (en) | 2018-03-05 | 2021-02-26 | 奥克梅斯制药爱尔兰有限公司 | Aripiprazole administration strategy |
CN115433116B (en) * | 2022-09-20 | 2023-07-14 | 徐州医科大学 | Acylated indoline derivative, composition and application thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU198036B (en) * | 1983-08-22 | 1989-07-28 | Hoechst Roussel Pharma | Process for production of derivatives of 3-piperidil-/1h/-indasole and medical preparatives containing them |
US5350747A (en) * | 1989-07-07 | 1994-09-27 | Pfizer Inc | Heteroaryl piperazine antipsychotic agents |
AP2005003250A0 (en) * | 2002-09-17 | 2005-03-31 | Warner Lambert Co | Heterocyclic substituted piperazines for the treatment of schizophrenia. |
RU2005112254A (en) * | 2002-10-24 | 2006-01-20 | Пфайзер Продактс Инк. (Us) | Acyl derivatives of 5- (1,2-benzisothiazol-3-yl) -1-piperazinyl) ethyl) -6-chloro-1,3-dihydro-2n-indol-2-one having neuroleptic activity |
-
2004
- 2004-12-20 CA CA002551346A patent/CA2551346A1/en not_active Abandoned
- 2004-12-20 BR BRPI0418255-3A patent/BRPI0418255A/en not_active IP Right Cessation
- 2004-12-20 EP EP04806416A patent/EP1701954A1/en not_active Withdrawn
- 2004-12-20 JP JP2006546393A patent/JP2007517014A/en active Pending
- 2004-12-20 WO PCT/IB2004/004239 patent/WO2005066165A1/en not_active Application Discontinuation
- 2004-12-20 MX MXPA06007654A patent/MXPA06007654A/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2005066165A1 (en) | 2005-07-21 |
MXPA06007654A (en) | 2006-09-04 |
EP1701954A1 (en) | 2006-09-20 |
JP2007517014A (en) | 2007-06-28 |
CA2551346A1 (en) | 2005-07-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0418255A (en) | unsubstituted piperazine and piperidine derivatives | |
BR0208338A (en) | Pyridine Derivatives | |
BR0314393A (en) | Heterocyclic Substituted Piperazines for the Treatment of Schizophrenia | |
BRPI0413860A (en) | [1,8] Naphthyridin-2-ones and related compounds for the treatment of schizophrenia. | |
BRPI0510453A (en) | Substituted Morpholine Compounds for the Treatment of Central Nervous System Disorders | |
BR0312560A (en) | New tricyclic spiropiperidines or spiropyrrolidines | |
BRPI0408347A (en) | pyrimidine derivatives | |
BR0016396A (en) | New p2x7 receptor antagonists for use in the treatment of inflammatory, immune or cardiovascular diseases | |
BR0316350A (en) | Diaminotriazoles useful as protein kinase inhibitors | |
ATE377597T1 (en) | ANILINOQUINAZOLINES AS PROTEIN TYROSINE KINASE INHIBITORS | |
BR0113838A (en) | N-phenyl-2-pyrimidine amine derivatives | |
SE0104140D0 (en) | Novel Compounds | |
BR0310077A (en) | New compounds and their use | |
NO20054787L (en) | Indene derivatives as pharmaceuticals | |
BR0208741A (en) | Piperidine Derivatives | |
BRPI0413094A (en) | quinoline derivatives and their use in therapy | |
BRPI0414948A (en) | pyrazolo-e-imidazo pyrimidine derivatives | |
NO20020282D0 (en) | New diphenylpiperidine derivative | |
BR0313385A (en) | Pyrimidine-2,4-dione derivatives as matrix metalloproteinase inhibitors | |
SE9901077D0 (en) | Novel use | |
BRPI0607918A2 (en) | tetrahydro-pyridoazepin-8-ones and related compounds for the treatment of schizophrenia. | |
BR0316108A (en) | Phenylalkyl and pyridylalkyl piperazine derivatives and pharmaceutical composition comprising them | |
BR0103048A (en) | N-triazolylmethyl-piperazine derivatives as neurokinin receptor antagonists | |
SE9902551D0 (en) | Novel compounds | |
BR0114380A (en) | 1-Aminobutan-3-ol-substituted derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application fees: dismissal - article 86 of industrial property law |
Free format text: REFERENTE AS 4A, 5A, 6A E 7A ANUIDADES. |
|
B08K | Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87) |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012. |